News
Jagsonpal Pharmaceuticals standalone net profit rises 102.63% in the June 2025 quarter
26-Jul-2025 | 13:38
Sales rise 23.06% to Rs 75.61 crore
Net profit of Jagsonpal Pharmaceuticals rose 102.63% to Rs 10.80 crore in the quarter ended June 2025 as against Rs 5.33 crore during the previous quarter ended June 2024. Sales rose 23.06% to Rs 75.61 crore in the quarter ended June 2025 as against Rs 61.44 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 75.61 | 61.44 | 23 |
| OPM % | 18.79 | 16.68 | - |
| PBDT | 16.79 | 11.47 | 46 |
| PBT | 14.44 | 10.40 | 39 |
| NP | 10.80 | 5.33 | 103 |
Powered by Capital Market - Live News